Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
PaperCitations, authors & open-access status
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 295 citations, 2017 year and bronze oa status.
295
Citations
2017
Year
bronze
OA Status